Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Prehab to get stronger before pancreatic cancer surgery

Official title: Multimodal Prehabilitation Prior to Pancreatic Cancer Surgery: A Pilot Study

Run by University of Massachusetts, Worcester · NCT07478185 · Data updated 2026-11-12

This project will test whether adults with pancreatic cancer can follow a combined exercise, nutrition, and symptom-management program during chemotherapy to improve fitness and recovery before surgery.

More Prehabilitation trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorUniversity of Massachusetts, Worcester
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Worester, Massachusetts)
StatusRecruiting
StartedMarch 31, 2026
Main results expectedFebruary 2028
Study endsDecember 2028
Registry record updatedApril 3, 2026
Trial IDNCT07478185 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age ≥18) with pancreatic ductal adenocarcinoma scheduled for neoadjuvant chemotherapy and planned surgical resection who are medically cleared for exercise and able to read and understand English are ideal candidates.

Probably not a fit

Patients who are medically unfit for physical activity (for example with unstable cardiac or severe pulmonary disease), who have severe cognitive impairment, are pregnant, incarcerated, or cannot participate in English are unlikely to be eligible or benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center, prospective pilot embeds a standardized multimodal prehabilitation program into routine care for adults receiving neoadjuvant chemotherapy before planned pancreatic resection. The intervention combines coordinated physical activity, nutritional optimization, and supportive symptom management delivered throughout the chemotherapy period. Participants complete functional fitness tests and patient-reported surveys at baseline, after the prehabilitation period before surgery, and about one month after surgery, with perioperative clinical data abstracted from the medical record. Analyses are descriptive and exploratory, focused on feasibility, adherence, program delivery, and perioperative changes to inform future larger trials.

Why it matters

Potential benefit: If successful, the program could help patients enter surgery in better physical condition, which may reduce complications and speed early recovery.

How similar studies have gone: Prehabilitation has shown benefits in other major abdominal and cancer surgeries, but its delivery during neoadjuvant chemotherapy for pancreatic cancer is relatively untested and remains exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* Diagnosis of pancreatic ductal adenocarcinoma (PDAC)
* Planned neoadjuvant chemotherapy prior to planned surgical resection
* Medically stable and cleared to participate in physical activity/exercise programming
* Able to provide informed consent
* Ability to read, write and understand English

Exclusion Criteria:

* Age \<18 years
* Pregnant
* Prisoner
* Severe cognitive impairment that precludes informed consent or participation
* Contraindications to physical activity, including unstable cardiac disease, severe pulmonary disease, or recent myocardial infarction

Where it's running

  • UMass Memorial Medical Center
    Worester, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.